J. Thomas Ray

AbbvieCS — Int/Div — Buy

AcadiaCS — None — Buy

Agios CS — None — Sold

Alexion CS — None — Sold

Allergan CS — Int/Div — Buy

Amgen — Int/Div — Buy

Bank of America CS — Int/Div

Barrick Gold CS. — Int/Div — Sold

Berkshire Hathaway (B) C.S — None

Biogen C.S — None

BP PLC ADR — Int/Div — Sold

Bristol Mevers C.S — Int/Div

Celgene CS. — None — Buy (add'l)

Cenovus Energy Inc. C.S. — Int/Div — Sold

Chevron CS. — Int/Div

Cisco CS. — Int/Div — Sold

Coming CS. — Int/Div — Sold

Conoco Phillips C.S — Int/Div

Dow Chemical Co. CS. — Int/Div — Sold

Eh Lilly CS — Int/Div — Sold (part)

Encana Corp. CS. — Int/Div — Sold (part)

Enterprise Products CS — Int/Div — Buy

Exxon Mobil Corp. CS — Int/Div

Fairfax Financial Hldgs C.S — Int/Div — Sold

Freeport McMorran CS. — None

Gilead. CS — Int/Div — Buy (add'l)

HP Inc..CS. — Int/Div — Sold

Hewlett Packard ENTE, CS — None — Sold

mel CS. — Int/Div

J P Morgan Chase CS. — Int/Div

Johnson & Johnson C.S — Int/Div

Lexmark Intl Inc. CS. — Int/Div — Sold

Medivation Inc. CS — None — Sold

Merck & Co. Inc. CS — Int/Div

National Oilwell Varco CS. — None — Sold

Newmont Mining C.S — Int/Div — Sold

Peabody Energy Corp. C.S — None — Sold

Permian Basin Trust CS. — Int/Div

Phizer inc. CS — Int/Div

Phillips 66 CS. — Int/Div

Philllips 66 Partners C.S — Int/Div — Buy

Precision Drilling C.S — None — Sold

Rio Tito ADR — Int/Div — Sold

Roche ADR — Int/Div — Buy (add'l)

Regeneron Inc — None — Buy

Sanofi Aventis CS — Int/Div

Seacor Holdings CS — None — Sold

Seattle Genetics, Inc. CS — None — Buy

Stryker Corp. CS — Int/Div

Teck Resources C.S. — None — Sold

Tejon Ranch Co. C.S. — None — Sold

Tsakos CS — Int/Div — Sold

Vale ADR — Int/Div — Sold

Valero Energy C.S — Int/Div

Wells Fargo CS. — Int/Div

Weverhauser Co CS — Int/Div — Sold

UCA Rev. Bond — Interest — Redeemed

Charles Schwab Money Market (Cash Equivalents) — Interest

ORVAcadia & Ver. Par, LA; McGowan Inc.; Zachry Exploration — Rovalty

ORVRegan County, TX/Pioneer Natural Resources — Rovalty

W/L Acadia & Vermillion Par, LA: McGowan Inc. — Rovalty

ORVAcadia Par, LA; Zachry Eploraton (X) — Rovalty

Rental Property (Pulaski County, AR) — Rent

Rollover IRA (H)

Charles Schwab Money Market (Cash Equivalents) — Interest

Acadia Pharmaceuticals CS — None — Buy

Agios CS — None — Sold

Allergan C.S — Int/Div — Buy

Amgen CS — Int/Div

Bank of America. CS. — Int/Div

Barrick Gold Corp. CS. — Int/Div — Sold

Berkshire Hathaway (B) CS — None

Bwgen CS — None

BP ADR — Int/Div — Sold

Celgene CS. — None — Sold (part)

Chevron CS. — Int/Div — Sold (part)

Conoco Phillips C.S — Int/Div

Encana Corp CS. — Int/Div — Sold

Exxon CS — Int/Div

Freeport McMorun C.S — None — Sold

General Electric Co. CS — Int/Div — Sold

Gilead Sciences Inc. CS — Int/Div

J.P. Morgan CS. — Int/Div — Sold (part)

Johnson & Johnson CS — Int/Div

Kinder Morgan Inc. C.S — Int/Div

Merck & Co. Inc. CS. — Int/Div

Medivation C.S — None — Sold

Pfizer Inc. CS — Int/Div

Phillips66 CS — Int/Div

Phillips 66 Partners L.P — Int/Div — Buy

Regeneron CS — None — Buy

Roche Hldg ADR — Int/Div

Sanofi Aventis CS — Int/Div

Schlumberger CS — Int/Div — Sold

Stemline Therapeutics C.S — None

Transocean Inc. CS — None — Sold

Wells Fargo & Co. CS — Int/Div — Sold

Whiting Petroleum C.S — None — Buy

IRA #1 (H)

Abbvie CS — Int/Div — Buy

Agios C.S. — Sold

Acadia Pharm. C.S — None — Buy

Allergan C.S — Int/Div — Buy

Amgen Inc. CS — Int/Div

Bank of America CS — Int/Div — Sold

Barrick Gold Corp. CS. — Int/Div — Sold

Berkshire Hathaway (B) C.S — None

BPPLCCS. — Int/Div — Sold

Celgene CS — None

Conoco CS. — Int/Div

Dow Chemical Co CS. — Int/Div — Sold

Exxon Mobil CS. — Int/Div

Freeport McMoran — None

Gilead Sciences Inc. CS — Int/Div

Johnson & Johnson C.S. — Int/Div

J.P. Morgan Chase CS — Int/Div

Merck CS. — Int/Div

Phillips 66 C.S — Int/Div

Phizer CS. — Int/Div

Stemline Therapeutics C.S — None

Transocean Inc. CS — None — Sold

Whiting Petroleum — None — Sold

Charles Schwab Money Market (Cash Equivalents) — Interest

Inherited IRA (H)

AbbVie Inc. CS. — Int/Div

Acadia Pharm. C.S — None — Buy

Agios CS — None

Allergan C.S. — None

Alexion C.S. — None — Sold

Berkshire Hathaway C.S — None

Biogen Inc. CS — None

Celgene CS — None

Chevron CS. — Int/Div

Coca Cola CS. — Int/Div — Sold

Conoco Phillips CS — Int/Div

Diageo PLC ADR — Int/Div — Sold

Gilead Science Inc. CS. — Int/Div

Honevwell Inc. CS — Int/Div — Sold

Johson & Johnson C.S — Int/Div

Medivation Inc. CS — None — Sold

Merck CS. — Int/Div

Mondelez CS. — Int/Div — Sold

Occudental CS. — Int/Div — Sold

Pfizer CS — Int/Div

Proctor & Gamble CS. — Int/Div

Time Warmer Inc. CS. — Int/Div — Sold

Wells Fargo & Co. CS. — Int/Div

Whiting Petroleum C.S — None

Dodge & Cox Intl. Stock M.F — Int/Div — Sold

Matthews Pacific Tiger MF — Int/Div

Pimco Commodities Plus MF — Int/Div — Sold

Preimeap Odyssey Stock M.F — Int/Div

T. Rowe Price Overseas MF — Int/Div

Charles Schwab Money Market (Cash Equivalents) (X) — Interest

IRA #2 (H)

Allergan C.S — None — Buy

Amgen Inc. CS. — Int/Div

Bank of America CS — Int/Div

Bamick Gold Corp. CS — Int/Div — Sold

Berkshire Hathaway (B) CS — None

Celgene CS — None

Conoco CS. — Int/Div

Exxon CS. — Int/Div — Sold (part)

Gilead Sciences Inc. CS — Int/Div

Johnson & Johnson C.S — Int/Div

Merck CS. — Int/Div

Phizer Inc. CS. — Int/Div

Charles Schwab Money Market (Cash Equivalents) — Interest

Explanation |: The Note and Mortgage listed in Section VI. of my Financial Disclosure Report, dated August 4, 2016, is no longer being reported because the Note

has been paid in full. Tnow have no liabilities,

Explanation 2: My previous Financial Disclosure Reports have listed assets held in Trust # 1, Trust # 2, and Trust # 3, Beginning mn calendar year 2014, filers are

only required to report in Part VII assets held in trust if:

* the filer, the spouse, or dependent child: receives income, or

* has a beneficial interest mn principal or income from the trust or estate.

Pursuant to the above-quoted language from the Filing Instructions for Judicial Officers and Employees, the assets held in Trust # 1, Trust # 2, and Trust # 3 are

no longer required to be reported. Accordingly, those assets are not being disclosed in this Financial Disclosure Report, und will not be disclosed in any future

Fmancial Disclosure Reports.